W. Henley

First name
W.
Middle name
E.
Last name
Henley
Streeter, A. J., Rodgers, L. R., Masoli, J., Lin, N. X., Ble, A., Hamilton, W., & Henley, W. E. (2022). Real-world effectiveness of pneumococcal vaccination in older adults: Cohort study using the UK Clinical Practice Research Datalink. Plos One, 17, e0275642. http://doi.org/10.1371/journal.pone.0275642
Streeter, A. J., Rodgers, L. R., Hamilton, F., Masoli, J. A., Ble, A., Hamilton, W. T., & Henley, W. E. (2022). Influenza vaccination reduced myocardial infarctions in UK older adults: a prior event rate ratio study. J Clin Epidemiol. http://doi.org/10.1016/j.jclinepi.2022.06.018
Melzer, D., Tavakoly, B., Winder, R. E., Masoli, J. A., Henley, W. E., Ble, A., & Richards, S. H. (2015). Much more medicine for the oldest old: trends in UK electronic clinical records. Age Ageing. http://doi.org/10.1093/ageing/afu113
Ble, A., Masoli, J. A., Barry, H. E., Winder, R. E., Tavakoly, B., Henley, W. E., et al. (2015). Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12. BMC Geriatr. http://doi.org/10.1186/s12877-015-0143-8
Ble, A., Hughes, P. M., Delgado, J., Masoli, J. A., Bowman, K., Zirk-Sadowski, J., et al. (2017). Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study. J Gerontol A Biol Sci Med Sci. http://doi.org/10.1093/gerona/glw082
Bowman, K., Delgado, J., Henley, W. E., Masoli, J. A., Kos, K., Brayne, C., et al. (2017). Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients. J Gerontol A Biol Sci Med Sci. http://doi.org/10.1093/gerona/glw147
Rodgers, L. R., Weedon, M. N., Henley, W. E., Hattersley, A. T., & Shields, B. M. (2017). Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes. BMJ Open. http://doi.org/10.1136/bmjopen-2017-017989
Dennis, J. M., Henley, W. E., Weedon, M. N., Lonergan, M., Rodgers, L. R., Jones, A. G., et al. (2018). Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data. Diabetes Care. http://doi.org/10.2337/dc18-0344
Dennis, J. M., Shields, B. M., Hill, A. V., Knight, B. A., McDonald, T. J., Rodgers, L. R., et al. (2018). Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy. Diabetes Care. http://doi.org/10.2337/dc17-1827
Dennis, J. M., Henley, W. E., McGovern, A. P., Farmer, A. J., Sattar, N., Holman, R. R., et al. (2019). Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010-2017. Diabetes Obes Metab. http://doi.org/10.1111/dom.13687